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FABP7
FABP7
FABP7  (FABP7-KO) lipopolysaccharide (LPS) 
toll-like receptor 4 (TLR4) 
 (mitogen-activated protein kinases (MAPKs) nuclear factor-kappa B 
(NF- B)) tumor necrosis factor-  (TNF- ) 
FABP7-KO glial cell-line derived neurotrophic factor (GDNF) 













(Parolini et al. 1999; Rothberg et al. 1992)  (cavin) 
 (Bastiani et al. 2009; Izumi et al. 1997; Mineo et al. 1998; 
Vinten et al. 2001) cavin-1 caveolin
 (Harvey and Calaghan 2012; Voldstedlund 
et al. 2003) (Fig. 1)
Fig.1. Structure of caveolae and its compornents Caveolae are specialised lipid rafts 
enriched in cholesterol and sphingolipids, characterised by the presence of caveolin and 
cavin proteins. Cartoon of a caveolae depicting the organisation of caveolin (red) and 
cavin (green) proteins. Figure taken form “Harvey et al. 2012” with modification. 
TLR4
LPS Toll/IL-1R (TIR) 
domain-containing adapter protein TIR domain-containing adapter inducing 
IFN- -related adapter molecule
MAPKs NF- B  (Allen et al. 2007; Piao et al. 2013; 
Triantafilou et al. 2002) (Fig. 2)
Fig.2. Membrane organization of transmitter signaling molecules The lipid raft 
signalling proposes that microdomains spatially organize signalling molecules at the 
membrane to promote kinetically interactions that are necessary for signal transduction. 
Alternatively, lipid raft microdomains inhibit interactions by separating signalling 
molecules, thereby dampening signalling responses. Figure taken form “Allen et al. 
2007”. 
GDNF  (Tansey et al. 2000; Trupp et al. 
1999) epidermal growth factor (EGF)  (Hofman et al. 2008) RAS
 (Roy et al. 1999)  (Mastick et al. 1995)
 (Incardona and Eaton 2000) 
 (Benveniste 
1998)
 (Cannella and Raine 1995)  (Akiyama 
et al. 1993)  (Dong and Benveniste 2001) 
 (polyunsaturated fatty 
acids: PUFAs)  (Williams et al. 2012)
 (docosahexaenoic acid: DHA) 
 (eicosapentaenoic acid: EPA) n-3 PUFAs
 (Schley et al. 2007)
 (Lauritzen et al. 
2000)  (Fan et al. 2004)  (Jolly 
et al. 1997) T  (Arrington et al. 2001) 
n-3 PUFAs  (Kremer et al. 1985)
 (Arm et al. 1988)  (Weinstock-Guttman et al. 2005)




Acid Binding Protein: FABP) PUFAs
14-15 kDa FABP
 (Jefferson et al. 1990)  (Glatz et al. 1995)
(Furuhashi and Hotamisligil 2008) 
peroxisome proliferator-activated receptor
 (Wolfrum et al. 2001) (Fig.3) FABP 12
FABP7 brain-typed FABP  (Owada et al. 1996) 
FABP7
 (Watanabe et al. 2007) FABP7
(FABP7-KO)
(Owada et al. 2006)  (Kipp et al. 2011)





Fig. 3. Cellular functions of FABPs Scheme showing putative cellular functions of 
FABPs through trafficking of fatty acids to specific compartments in the cell such as 
membrane (composition of phospholipid); mitochondria (oxidation); endoplasmic 
reticulum (ER stress); cytosolic (intracellular signaling); nucleus (transcriptional 





) (Fig. 4) FABP7
FABP7
FABP7
 ( ) 
Fig. 4. LPS-TLR4 signaling Scheme shows well-known LPS-TLR4 signaling cascade. 
LPS induces TLR4 recruitment into lipid rafts (caveolae), activation of its downstream 
cascade including MAPKs and NF- B signaling and production such as TNF- . In this 
study, we focused whether FABP7 is involved in these cascades.    
4-1.
anti-mouse FABP7
(Abdelwahab et al. 2003) anti-caveolin-1 glial fibrillary acidic protein (GFAP)
(Cell Signaling Technology, MA, USA) anti-cavin-1 cavin-3  (Abcam, 
Cambridge, England) anti-early endosome antigen-1 (EEA-1)  (BD Transduction 
Laboratories, CA, USA) goat anti-rabbit IgG-Alexa488
goat anti-guinea-pig IgG-Alexa 555 goat anti-rat IgG-Alexa568 (Life Technologies, CA, 
USA) 
anti- total-I B- p38 MAPK
phospho-p38 MAPK (Thr180/Tyr182) SAPK/JNK phospho-SAPK/JNK 
(Thr183/Tyr185) p44/42MAPK (Erk1/2) phospho-p44/42 MAPK (Erk1/2) 
(Thr202/Tyr204)  (Cell Signaling Technology, MA, USA) anti-non-phospho- 
I B- TLR4 GFR 1 caveolin-1 flotillin-1 -actin  (Santa Cruz Biotechnology, 
TX, USA) anti-cavin-1 cavin-3 (Abcam, Cambridge, England) 
horseradish peroxidase (HRP)-conjugated goat-anti rabbit IgG
HRP-conjugated goat anti-mouse IgG  (Merck Millipore, MA, USA) 
 (Table 1)
Table.1 List of primary antibodies used in this study 
4-2. 
C57BL/6J  ( ) 
FABP7-KO
 (Owada et al. 2006) 0.8 mg/ml 
protease K (Promega, WI, USA) DNA PCR





Sharifi  (Sharifi et al. 2011)
 (P0-1) 20 
mM D-glucose 1 Penicillin-Streptmycin (Gibco, USA) Hanks’ balanced 
salt solutions (Sigma, USA) 
0.25% trypsin (Gibco) 37 10
10% fetal bovine serum (FBS) (Hyclone, USA) 1% 
Penicillin-Streptmycin Dulbecco’s modified Eagle’s medium (DMEM, 
Invitrogen, USA) 
100 m  (Falcon, USA) 1300  rpm 5
DMEM T75
 (Falcon) 20×106 37 5% CO2








FBS, 1% Penicillin-Streptmycin DMEM
LPS (Escherichia coli O111:B4 Sigma-Aldrich Japan) GDNF (Pepro Tech Inc. 
NJ, USA) Semple LPS 10-10000 ng/ml
0 24  (Semple et al. 2010) Pierchala
GDNF 50 ng/ml 10
 ( ) Murphy
N,N-Dibutyladenosine 3',5'-phosphoric acid (db-cAMP, Sigma-Aldrich 
Japan) 250 M 21 3 db-cAMP
 (Murphy et al. 1997)
FABP7 Liao
Madeira
MG132 (Sigma-Aldrich Japan) 5 M 24
MG132 0.1 DMSO
(Liao et al. 2013; Madeira et al. 2011)
4-5. 
MTS [3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt] 
MTS CellTiter 96 Aqueous 
nonradioactive cell proliferation assay kit (Promega) 
490 nm Multi-Spectrophotometer (Viento
) KC4TM version3.0 software
4-6. ELISA TNF-
LPS 1,000 rpm, 10 4°C
-20 TNF-  ELISA kit (R&D 
system) TNF-
490 nm Multi-Spectrophotometer (Viento ) KC4TM version 
3.0 software
4-7. Real-time PCR
RNeasy plus Mini kit (Qiagen) total RNA
total RNA
 (Promega) DU 640 spectrophotometer (Beckman coulterTM, USA) 
RNA anchored-oligo(dt)18
Transcriptor High Fidelity cDNA Synthesis Kit (Roche, Suisse) 
Real-time PCR Applied Biosystems 
StepOnePlusTM real-time PCR system (Applied Biosystems, USA) 
TaqMan  (Applied Biosystems) glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH): Mm03302249_g1, FABP7: Mm00445225_m1, TNF- : 
Mm00443258_m1, TLR4: Mm00445273_m1, GFR 1: Mm00439086_m1, caveolin-1: 
Mm00483057_m1, caveolin-2: Mm00516827_m1, cavin-1 (Ptrf): Mm00477266_m1, 
cavin-2 (Sdpr): Mm00507087_m1, cavin-3 (Prkcdbp): Mm00466330_g1, cavin-4 
(Murc): Mm00471507_m1 and flotillin-1: Mm01275485_m1
GAPDH Ct  (cycle threshold) Ct
Ct Ct Ct




LPS (1,000 g/mL) 4
FABP7-KO 3 RNA integrity number (RIN) 
9.5 RIN RNA6000 nano kit
Agilent 2100 Bioanalyzer (Agilent, CA, USA) 
GeneChip® Mouse Gene 1.0 ST Array (Affymetrix) Ambion® 
WT Expression kit (Life Technologies) Affymetrix® GeneChip® WT Terminal 
Labeling kit (Affymetrix) 200 ng total RNA cDNA




 (Park et al. 2009; Wong et al. 2009)
8×106  (PBS) 2 MEB buffer 
(20 mM 2-Morpholinoethanesulfonic acid, monohydrate (MES) (Sigma-Aldrich Japan), 
150 mM NaCl, 1% Triton-X protease inhibitor (Roche, Suisse), pH6.5) 1.5 ml
10
13 PET  (HITACHI, Japan) 80%
/MEB buffer 30% /MEB buffer
5 ml 5% /MEB buffer 3ml P40ST
 (HITACHI) 4 21 40000 rpm
1 ml
/  ( 15%) 
SDS-PAGE sample buffer
4 7 8 11
BCA
4-10. 
 (Roche Diagnostics, Mannheim, 
Germany) SDS-PAGE sample buffe BCA protein 
Assay Kit 10%  15% 
SDS-polyacrylamide Immobilon-PSQ polyvinylidene difluoride 
membrane (Millipore, USA) 5% BSA 
(Wako, Japan)  0.1% Tween-20 (Wako) Tris-buffered saline
1 4
1 ECL kit (Amersham Pharmacia Biotech, Piscataway, NJ, 
USA) NIH image J
4-11. 
PBS 2 4% 5




phenylindole (DAPI, life Technologies, CA, USA) 
 (Zeiss LSM510META, Carl Zeiss, Oberkochen, Germany) 
Caveolin-1 Zen software (Carl Zeiss) 
40 m 2 m
1 10 10
caveolin-1 EEA-1
Ippolito NIH Image J Puncta analysis
FABP7-KO
4-12. 
Head Amplex  Red cholesterol 




BLOCK-iT Inducible PolII miR RNAi expression vecor kit with EmGFP (Life 
Technologies) 
cDNA FABP7 cDNA caveolin-1 
cDNA PCR pDONR221
pENTR™-mFABP7 ( mCav-1) 
pENTR5/CMV promoter pLenti6.4/R4R2/V5- DEST
pLenti6.4/CMV/mFABP7 ( mCav-1) 
293FT 10% FBS 1% penicillin-streptomycin 1% sodium pyruvate (Wako, 
Tokyo, Japan) 1% non-essential amino acids (Sigma Aldrich Japan) DMEM
Lipofectamine 2000 (Life Technologies) pLenti6.4/CMV/ 
mFABP7 ( mCav-1) 72










 (Wong et al. 2009) n-3
 (Lee et al. 2003; Wong et al. 2009) 
LPS TLR4 FABP7
FABP7 LPS
 (Fig. 5A, B) FABP7-KO
LPS 10 TLR4
 (Fig. 5D, E) FABP7-KO TLR4
 (Fig. 5C)
flotillin-1 FABP7-KO
 (fraction 4 7) LPS
 (Fig. 5D, F) TLR4
 (fraction 8-11) 
TLR4 FABP7-KO
LPS TLR4
 (Fig. 5G, H, I)

Fig. 5. FABP7-deficiency in astrocytes decreased the recruitment of TLR4 into lipid 
raft fractions after LPS stimulation.
(A) Protein level of FABP7 in astrocytes in the presence or absence of LPS was 
evaluated by Western blotting. Astrocytes were stimulated with LPS (1,000 ng/mL) for 
0, 1, 4, 8, 12 and 24 h. Total proteins from WT and FABP7-KO olfactory bulb were 
used as a positive and a negative control, respectively. Band density was analyzed using 
NIH-Image J. -actin was used as loading control. (B) Localization of FABP7 in 
astrocytes before and after LPS stimulation for 10 min was examined by 
immunofluorescence staining. (FABP7 (green), nucleus (blue)), scale bar: 50 m (C) 
Protein level of TLR4 in astrocytes in the presence or absence of LPS was evaluated by 
Western blotting. (D) Recruitment of TLR4 and accumulation of flotillin-1 to lipid raft 
fractions 10 min after LPS stimulation were measured by Western blotting. The 9 
fractions from the top of gradient were shown. Coomassie brilliant blue staining showed 
that the proteins of lipid raft fractions from WT and FABP7-KO astrocytes were equally 
isolated and loaded in SDS-PAGE. (E, F) The sum of fraction 4-7 density of TLR4 and 
flotillin-1 were analyzed using NIH-Image J. (G) The levels of TLR4 and flotillin-1 in 
total pool, lipid raft fraction pool and non-lipid raft fraction pool with or without LPS 
stimulation for 10 min were measured by Western blotting. (H, I) Band density of TLR4 
protein levels in lipid raft pool and non-lipid raft pool was analyzed using NIH-Image J. 
Data shown are the means ± s.e.m. and representative of 3 independent experiments. 




 (Fig. 6C) FABP7-KO GDNF
GFR  (Fig. 6A, B)
GDNF GFR FABP7- 
KO  (Fig. 6C, D, E)
FABP7-KO
Fig.6. FABP7-deficiency in astrocytes decreased the accumulation of GFR 1 in lipid 
raft fractions after GDNF treatment. (A) Accumulation of GFR 1 in lipid raft fractions 
10 min after GDNF treatment (50 ng/ml) was evaluated by Western blotting. Coomassie 
brilliant blue staining showed that the proteins of lipid raft fractions from WT and 
FABP7-KO astrocytes were equally isolated and loaded in SDS-PAGE. (B) The sum of 
fraction 4-7 density of GFR 1 before and after GDNF treatment were analyzed using 
NIH-Image J. (C) The levels of GFR 1 and flotillin-1 in total pool, lipid raft fraction 
pool and non-lipid raft fraction pool with or without GDNF treatment for 10 min were 
evaluated by Western blotting. (D, E) Band density of GFR 1 protein level in lipid raft 
pool and non-lipid raft pool was analyzed using NIH-Image J. Data shown are the 
means ± s.e.m. and representative of 3 independent experiments. *p<0.05; Student’s 
t-test versus WT astrocytes 
5-2. FABP7-KO
FABP7-KO
LPS TLR NF- B
MAPKs MAPKs (ERK1/2 (ERK)
p38MAPK (p38) SAPK/JNK (JNK)) 
FABP7-KO LPS 30 ERK p38
JNK  (Fig. 7A) I B-
FABP7-KO
LPS 30 I B-  (Fig. 7A)
I B-  ( I B- I B- ) 




 (TNF- , interleukin-6 (IL-6)  chemokine 
(C-C motif) ligand 7 (CCL7)  C-X-C motif chemokine 5 (Cxcl5) monocyte 
chemotactic protein-1 (MCP-1)) FABP7-KO
 (Fig. 7B) LPS TNF-  mRNA
Real-time PCR TNF- ELISA
TNF- FABP7-KO




Fig. 7. FABP7-deficiency in astrocytes decreased the activity of MAPKs (p38, ERK1/2, 
JNK) and NF- B, and TNF-  production after LPS stimulation. (A) Induction of 
phosphorylation of p38MAPK, ERK1/2, SAPK/JNK and I B-  after LPS stimulation 
(1,000 ng/mL) was examined by Western blotting. The non-phospho-I B-  antibody 
detected just non-phospho-protein and total I B-  antibody detected both phospho- and 
non-phospho-I B- . The p38MAPK, ERK1/2, and SAPK/JNK antibodies detected total 
protein. (B) Gene expression of TNF- , IL-6, Ccl7, Cxcl5 and MCP1 4 h after LPS 
stimulation was examined by microarray analysis. (C) Gene expression of TNF- was 
examined by qPCR. (D, E) Production of TNF-  after LPS stimulation was measured 
by ELISA. (D) Astrocytes were stimulated with LPS for 24 h. (E) Astrocytes were 
stimulated with LPS (1,000 ng/ml). Data shown are the means ± s.e.m. and 
representative of 3 independent experiments. # p<0.05; one-way ANOVA versus 
non-treated WT astrocytes, *<0.05; Student’s t-test versus WT astrocytes 
Fig. 8. Cell viability did not change after LPS stimulation between WT and 
FABP7-KO astrocytes. To evaluate the cell viability of WT and FABP7-KO astrocytes 
after LPS stimulation, the MTS assay (A, B) and trypan blue exclusion test (C, D) were 
performed. (A, C) Astrocytes were stimulated for 24 h with LPS (0, 10, 100, 1000 and 
10000 ng/ml). (B, D) Astrocytes were stimulated with LPS (1,000 ng/ml) for 0, 4, 8, 12 
and 24 h. 
5-3. FABP7-KO caveolin-1
Caveolin cavin flotillin-1 ( )
 (Bucci et al. 2000; Mundy et al. 2012)
caveolin-1 2 cavin-1 2 3 4 flotillin-1
real-time PCR caveolin-1 cavin-3
flotillin-1  (Table 2)
Table 2. The mRNA expression of caveolin-1, but not caveolin-2, cavin-1, 2, 3, 4 or 
flotillin-1 was decreased in FABP7-KO astrocytes before and after LPS stimulation.
The mRNA expression of caveolae-related molecules in WT and FABP7-KO astrocytes 
before and after LPS stimulation for 4 h was evaluated by qPCR. Data shown are the 
means±s.e.m. and representative of 3 independent experiments. *p<0.05; Student’s 
t-test versus WT astrocytes 
**
FABP7-KO caveolin-1 cavin-1 cavin-3
flotillin-1
FABP7-KO caveolin-1 LPS








caveolin-1  (Fig. 9C) FABP7-KO
caveolin-1
Fig. 9. FABP7-deficiency in astrocytes decreased the expression of caveolin-1. 
(A) Protein levels of caveolin-1, cavin-1, 3 and flotillin-1 with or without LPS 
stimulation (1,000 ng/mL) in total cell lysates were measured by Western blotting. Band 
density was analyzed using NIH-Image J. (B) Gene expression of caveolin-1, cavin-1, 
cavin-3 and flotillin-1 after LPS stimulation was examined by qPCR. (C) The level of 
caveolin-1 after treatment of MG132 (5 M) for 24 h was evaluated by Western blotting. 
Band density was analyzed using NIH-Image J. Data shown are the means ± s.e.m. and 





 (Fig. 10A, B, C, D, E, F)
Fig. 10. FABP7-deficiency in astrocytes decreased the accumulation of caveolin-1 in 
lipid raft fractions. (A) Accumulation of caveolin-1, cavin-1, 3 and flotillin-1 with or 
without LPS stimulation for 10 min in lipid raft fractions was measured by Western 
blotting. Coomassie brilliant blue staining showed that the proteins of lipid raft fractions 
from WT and FABP7-KO astrocytes were equally isolated and loaded in SDS-PAGE. (B, 
C, D) The sum of fraction 4-7 density of caveolin-1 (B), cavin-1 (C) and cavin-3 (D) 
were analyzed using NIH-Image J. (E) The levels of caveolin-1 and flotillin-1 in total 
pool, lipid raft fraction pool and non-lipid raft fraction pool with or without LPS 
stimulation for 10 min were evaluated by Western blotting. (F) Band density of 
caveolin-1 protein levels was analyzed using NIH-Image J. Data shown are the means ± 








 (Fig. 11A, B) cavin-1, cavin-3  (Fig. 
11A) caveolin-1
EEA-1  ( ) (Li et al. 2013) FABP7-KO
 (Fig. 11C, D, E) FABP7-KO
caveolin-1
caveolin-1
 (Head et al. 2011) FABP7-KO
 (Fig. 11H)
FABP7-KO  (Fig. 11F)
FABP7-KO  (Fig. 11G)
FABP7-KO caveolin-1
Fig. 11. FABP7-deficiency in astrocytes affected the caveolin-1-positive early 
endosome and the levels of cholesterol in lipid raft fractions. (A) The localization 
and expression of caveolin-1, cavin-1 and cavin-3 were evaluated by 
immunofluorescence staining. scale bar: 50 m (B) Fluorescence intensity of caveolin-1 
in the membrane and cytoplasm was evaluated by Zen software. (C) The expression of 
EEA-1 and co-localization of EEA-1 with caveolin-1 were evaluated by 
immunofluorescence staining (caveolin-1 (green), EEA-1 (red)). scale bar: 50 m (D, 
E) The levels of EEA-1-positive compartments and co-localization of EEA-1 with 
caveolin-1 were analyzed using puncta analyzer. (F, G, H) The levels of cholesterol in 
lipid raft (fraction 4-7), in non-lipid raft (fraction 8-11) and in total cells were evaluated. 
Data shown are the means ± s.e.m. and representative of 3 independent experiments. 








 (Fig. 12B) caveolin-1
FABP7-KO caveolin-1
LPS TLR4 TNF-
 (Fig. 12C) FABP7-KO
caveolin-1
Fig. 12. Rescue expression of caveolin-1 in FABP7-KO astrocytes improved TLR4 
recruitment into lipid raft fractions and TNF-  production after LPS treatment.
(A) The levels of FABP7, caveolin-1 and TLR4 in FABP7-reexpressed- and caveolin-1- 
transfected-FABP7-KO astrocytes were evaluated by Western blotting. LacZ-expressed 
FABP7-KO astrocyte (CTRL) was used as control. Band density of caveolin-1 protein 
level was analyzed using NIH-Image J. (B) The localization and expression of 
caveolin-1 in FABP7-reexpressed FABP7-KO astrocytes were evaluated by 
immunofluorescence staining. scale bar: 50 m (C) Recruitment of TLR4 and levels of 
caveolin-1 and flotillin-1 in lipid raft fractions 10 min after LPS stimulation in 
caveolin-1-transfected FABP7-KO astrocytes were measured by Western blotting. 
Coomassie brilliant blue staining showed that the proteins of lipid raft fractions from 
caveolin-1-transfected FABP7-KO and CTRL were equally isolated and loaded in 
SDS-PAGE. (D) Production of TNF-  after LPS stimulation in FABP7-reexpressed- and 
caveolin-1-transfected FABP7-KO astrocytes was measured by ELISA. Data shown are 
the means ± s.e.m. and representative of 3 independent experiments. *<0.05; Student’s 
t-test versus LacZ-expressed FABP7-KO astrocytes  








Fig. 13. There was no obvious morphological change before or after LPS stimulation 
between WT and FABP7-KO astrocytes cultured for 7 days or 21 days even though 
treated with db-cAMP. Morphology of primary cultured astrocytes was observed by 
phase-contrast microscopy. Astrocytes were treated with db-cAMP (250 M) for 7 days 
(7 DIC) or 21 days (21 DIC) after passage. At 7 DIC and 21 DIC, astrocytes were 
stimulated with LPS (1,000 ng/ml) for 4 h. scale bar: 100 m 
Fig. 14.  The mRNA expression of TNF- , caveolin-1 and FABP7 was decreased in 
WT astrocytes at DIC 21 compared with at DIC 7, and the difference in TNF-  and 
caveolin-1 levels between WT and FABP7-KO astrocytes was not detectable at DIC 
21. The mRNA expression of TNF-  (A), caveolin-1 (B) and FABP7 (C) was measured 
by qPCR. Astrocytes were treated with db-cAMP (250 M) for DIC 7 or DIC 21 after 
passage. At 7 DIC and 21 DIC, astrocytes were stimulated with LPS (1,000 ng/ml) for 4 
h. Data shown are the means ± s.e.m. and representative of 3 independent experiments. 
FABP7-KO LPS TLR4




Fig.15. Schematic illustration depicting the putative functions of FABP7 in the 
astrocytes (A) In WT astrocyte, FABP7 regulates the caveolin-1 gene expression. The 
receptors recruit into lipid rafts in response to the stimuli, and the downstream signaling 
is initiated. FABP7 suppresses the degradation of caveolin-1. (B) In FABP7-KO 
astrocyte, the decreased expression of caveolin-1 impaired lipid raft function and its 
downstream signaling. 
 (Pelkmans and Zerial 2005) Caveolin-1
 (Parolini et al. 1999; Simons and Toomre 
2000)
Cavin-1 caveolin-1
 (Hayer et al. 2010a)







 (D'Alessio et al. 2012) Caveolin-1 LPS
NF- B inducible nitric oxide synthase
intracellular adhesion molecule-1  (Garrean et al. 2006) 
caveolin-1 TGF- /smad1
 (Haines et al. 2012) caveolin-1
brain-derived neurotrophic factor
 (Head et al. 2011) MCF7
caveolin-1 IL-1
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TNF- MCP-1  (Van Der Voorn et 




 (Iwayama et al. 2010; Maekawa et al. 2010; Watanabe et al. 2007)
1
2.5  (Matute et al. 2005)
caveolin-1 caveolin-1-KO
 (PPI) 
 (Allen et al. 2011) caveolin-1-KO
FABP7-KO caveolin-1
FABP7
transient receptor potential canonical
 (Bomben et al. 2011) caveolin-1 connexin43
 (Strale et al. 2012) 
FABP7
 (De Rosa et al. 2012; Mita et al. 2010) 
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